Translate page

ESHCML2022 starts this FridayOctober 2022 - The 24th annual John Goldman Conference starts this Friday and we can’t wait to meet you there in person!

We are delighted to share that a sub-analysis of the iCMLf COVID-19 and CML CANDID data will be presented during a poster walk at the conference.

And we are very pleased that the iCMLf prize winners of the last few years will be awarded their medals in person at the conference and we look forward to the keynote lectures of the 2022 prize recipients.

Also come to visit us at the iCMLf booth to learn more about our programs, research alliances and campaigns.

And join us for the John Goldman Charity Fun Run on Sunday morning!

Logo Fun Run 2022 2October 2022 - Do you need motivation to run a 5km track? And do you want to support the work of the iCMLf? Then it’s time to join us for our annual John Goldman Charity Fun Run.

This year we will run together again. And this year, anyone can be involved!

If you are coming to the John Goldman Conference on CML in October, join us for the first face-to-face run in two years on Sunday morning.

If you can’t attend the conference, you can do your own 5 km run and join the CML community virtually.

All funds raised through this charity run will help the iCMLf to support young scientists and physicians from the emerging regions.

Let’s run together for a good cause.

Collage Cortes KrauseOctober 2022 - The 24th John Goldman Conference is just around the corner – again with an excellent scientific program and new, often unpublished data on CML. If you can’t attend the live program, or would like a recap after the conference, then join us to discuss clinical and biological highlights of the meeting during an iCMLf Conversation.

On Wednesday, October 26th at 14.00 Central European Summer Time, meeting co-chairs, Professor Jorge Cortes and Professor Daniela Krause, will provide an overview of the significant clinical and biological aspects presented during the conference. There will also be plenty of time for your questions and an open discussion.

Don’t miss this opportunity and save the date.

The first featured iCMLf Prize nominee is Dr Ali Bazarbachi, American University of Beirut, Lebanon

“CML is predicted to become the most prevalent leukemia by 2040 and accordingly an intensive global effort with more international collaborations between clinicians and researchers is imperative to find a definitive cure for CML.”cncr31258 fig 0001 m

Ali Bazarbachi, MD, PhD is a Professor of Medicine (Hematology and Oncology), Professor of Anatomy, Cell Biology and Physiological Sciences, and Director of the bone marrow transplantation program at the American University of Beirut-Medical Center. 

As part of the iCMLf’s mission to improve outcomes for people with CML around the world we are taking the opportunity to feature the achievements of those who work in the most resourced challenged areas.

“We rise by lifting others” – Robert Ingersoll

Earlier this year we continued the tradition of awarding the iCMLf Prize to people who dedicate their time and effort through research, study and humanitarianism, as a means to change the lives of those impacted by CML, specifically those in low and middle-income countries.

World CML Day 2022 still slideUnited in community and purpose - Towards a Cure for CML

On World CML Day 9/22 - We reflect on how much has been done and yet there is still much still to do!

See our message for World CML Day from the iCMLf